Profit and Loss Results Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
6.00
8.00
11.00
15.00
14.00
18.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
6.00
8.00
11.00
15.00
14.00
18.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
3.00
3.00
4.00
5.00
4.00
3.00
Operating Expenses
218.00
233.00
189.00
191.00
147.00
131.00
General and Administration Expenses
12.00
16.00
17.00
16.00
22.00
26.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
20.00
28.00
35.00
36.00
47.00
45.00
Operating Profit (PBDIT) excl Other Income
-13.00
-20.00
-24.00
-21.00
-32.00
-26.00
Other Income
0.00
0.00
0.00
0.00
-5.00
-2.00
Operating Profit (PBDIT)
-12.00
-18.00
-22.00
-19.00
-36.00
-28.00
Interest
218.00
233.00
189.00
191.00
147.00
131.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
1.00
2.00
2.00
1.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
98.00
-254.00
36.00
-212.00
-228.00
-260.00
Provision for Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
103.00
-245.00
45.00
-204.00
-211.00
-260.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-0.01
-0.17
-0.04
-0.14
-0.14
-0.18
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is -18.35% vs -27.55% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 35.26% vs 14.79% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is -6.78% vs 23.17% in Mar 2023
Profit After Tax
YoY Growth in year ended Mar 2024 is 142.09% vs -636.42% in Mar 2023
Compare Profit and Loss Results of Innovative Pharmaceutical Biotech Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(HKD)
Change(%)
No of Months
12
12
Operating Income
6.00
9,333.00
-9,327.00
-99.94%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6.00
9,333.00
-9,327.00
-99.94%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
3.00
292.00
-289.00
-98.97%
Operating Expenses
218.00
104.00
114.00
109.62%
General and Administration Expenses
12.00
735.00
-723.00
-98.37%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
20.00
10,101.00
-10,081.00
-99.80%
Operating Profit (PBDIT) excl Other Income
-13.00
-767.00
754.00
98.31%
Other Income
0.00
673.00
-673.00
-100.00%
Operating Profit (PBDIT)
-12.00
123.00
-135.00
-109.76%
Interest
218.00
104.00
114.00
109.62%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
0.00
223.00
-223.00
-100.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
98.00
-203.00
301.00
148.28%
Provision for Tax
0.00
27.00
-27.00
-100.00%
Profit After Tax
103.00
-230.00
333.00
144.78%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.0082
-0.385
0.38
97.87%
Profit And Loss - Net Sales
Net Sales 6.59 Million
in Mar 2024Figures in Million
YoY Growth in year ended Mar 2024 is -18.35% vs -27.55% in Mar 2023
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -13.43 Million
in Mar 2024Figures in Million
YoY Growth in year ended Mar 2024 is 35.26% vs 14.79% in Mar 2023
Profit And Loss - Interest
Interest 218.10 Million
in Mar 2024Figures in Million
YoY Growth in year ended Mar 2024 is -6.78% vs 23.17% in Mar 2023
Profit And Loss - Profit After Tax
Profit After Tax 103.40 Million
in Mar 2024Figures in Million
YoY Growth in year ended Mar 2024 is 142.09% vs -636.42% in Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
